KRAS Multiplex Mutation Screening Kit

KRAS Multiplex Mutation Screening Kit

KRAS activating mutations are associated to approximately 15~25% of patients with lung cancer and 20~50% of patients with colorectal cancer. KRAS Digital PCR Multiplex Mutation Screening Kit identifies possible 61 mutation sites in a single well in a rapid and cost-effective manner including KRAS exon 2, 3, and 4 mutation groups. The targets are determined by unlabeled multiplex primers and fluorescent labeled probes.

Features

• Superior performance: allows quantification and screening for multiple KRAS mutations in a single well
• High sensitivity: provides sensitive and precise detection down to 0.2% in a single well
• Simple workflow: allows screening of multiple samples in a rapid and cost-effective manner. Reaction time ~4 hours

*  This products is for research use only in US